Zobrazeno 1 - 10
of 56
pro vyhledávání: '"M. Hesdorffer"'
Autor:
M. Smeltzer, B. Bunn, Y.S. Choi, L. Coate, J. Corona-Cruz, A. Drilon, N. Duma, M. Edelman, M.J. Fidler, S. Gadgeel, Y. Goto, R. Herbst, M. Hesdorffer, K. Higgins, B. Labdi, T. Leal, S. Liu, J. Mazotti, S. Novello, S. Patel, S. Popat, R. Ramirez, K. Reckamp, N. Reguart, R. Soo, A. Tan, J. Wolf, S. Yano, B. Stiles, A. Baird
Publikováno v:
Journal of Thoracic Oncology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9414d4f34bbea79ce2758768d434313
http://europepmc.org/articles/PMC8523155
http://europepmc.org/articles/PMC8523155
Autor:
Diana Borthwick, B. Ivimey, M. Culligan, M. Guerin, C. Broderick, M. Duffy, M. Hesdorffer, Liz Darlison, J. McPhelim
Publikováno v:
Lung Cancer. 91:S34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74781f2147c53201c5520a5f1b5c3ca1
https://doi.org/10.1016/s0169-5002(16)30113-1
https://doi.org/10.1016/s0169-5002(16)30113-1
Publikováno v:
Journal of Clinical Oncology. 27:e15534-e15534
e15534 Background: Progression of malignant peritoneal mesothelioma to clinically evident disease is poorly understood. Operative cytoreduction and post-operative intraperitoneal chemotherapy, followed by a second operative cytoreduction with heated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98ffb104e66e2e2b4181c83adda9afe8
https://doi.org/10.1200/jco.2009.27.15_suppl.e15534
https://doi.org/10.1200/jco.2009.27.15_suppl.e15534
Publikováno v:
Journal of Clinical Oncology. 25:20510-20510
20510 Background: We have assayed in-vitro drug resistance and immunohistochemical staining for drug resistance markers (MDR-1, MRP) in patients with metastatic soft tissue sarcoma patients. We looked at resistance to Cisplatin, Doxorubicin, and Ifos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::600be07c74661ba7cfeb37287fd9d472
https://doi.org/10.1200/jco.2007.25.18_suppl.20510
https://doi.org/10.1200/jco.2007.25.18_suppl.20510
Publikováno v:
Journal of Clinical Oncology. 25:20519-20519
20519 Background: Malignant peritoneal mesothelioma is a rare tumor best managed by an interdisciplinary approach. The role of 18FDG-PET scans in monitoring patients with peritoneal mesothelioma has not been defined. Methods: Patients with peritoneal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbb696a0a586f7b7eb249405f6fd5a70
https://doi.org/10.1200/jco.2007.25.18_suppl.20519
https://doi.org/10.1200/jco.2007.25.18_suppl.20519
Autor:
M. E. Ginsburg, K.M. Steinglass, G.D.N. Pearson, R. Fawwaz, R.N. Taub, Joshua R. Sonett, M. Hesdorffer
Publikováno v:
Lung Cancer. 54:S43
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b6e875b050e6999b1b1ed76059b7da5
https://doi.org/10.1016/s0169-5002(07)70253-2
https://doi.org/10.1016/s0169-5002(07)70253-2
Publikováno v:
Lung Cancer. 54:S29
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::875bc0fc179db3c6feba5b092c83c112
https://doi.org/10.1016/s0169-5002(07)70192-7
https://doi.org/10.1016/s0169-5002(07)70192-7
Publikováno v:
Journal of Clinical Oncology. 24:17133-17133
17133 Background: A prior phase II trial of oxaliplatin and gemcitabine in malignant pleural mesothelioma reported activity with a 40% partial response rate and stable disease in 24% of 25 previously untreated patients (Schutte W. et al., Clin Lung C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cb7ef872df94dbf91a5bc27a127ea87
https://doi.org/10.1200/jco.2006.24.18_suppl.17133
https://doi.org/10.1200/jco.2006.24.18_suppl.17133
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.